STVN
Stevanato Group S.p.A.
stockNYSE
founded in 1949, stevanato group is committed to create systems, processes and services that guarantee the integrity of parenteral medicines. it is comprised of two operational divisions: - pharmaceutical systems (ompi and balda brands): specialized in ready-to-use glass containers and bulk primary packaging (syringes, cartridges, vials and ampoules); high quality and high precision plastic solutions for diagnostic, pharmaceutical and medical device applications. - engineering systems (spami, optrel, innoscan and svm brands): specialized in glass forming technology, inspection systems, assembly, packaging machines and serialization solutions for the pharmaceutical industry. these two divisions enjoy a close, synchronous relationship, featuring daily exchanges which ensure that stevanato group has complete control over the entire production process, from purchasing the finest raw materials to offering exceptional after-sales customer service. the group also benefits from the sglab activ
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 21.41 | 2026-09-28 | -5.65% | 1.895 |
| 1M | 20.51 | 2026-09-04 | -1.51% | -0.791 |
| 3M | 19.28 | 2026-07-06 | +4.77% | -0.444 |
| 6M | 13.79 | 2026-04-06 | +46.48% | 0.366 |
| 1Y | 25.98 | 2025-10-03 | -22.25% | 1.085 |
| 2Y | 18.97 | 2024-10-04 | +6.48% | — |
| 5Y | 23.65 | 2021-10-04 | -14.59% | 0.896 |
Stevanato Group S.p.A. (NYSE:STVN) stock price today is $20.20, and today's volume is 189,923. STVN is up 1.098% today. The 30 day average volume is 338,271. STVN market cap is $5.52B with 273.13M shares outstanding.